期刊文献+

TRF及其在肿瘤中作用的研究进展 被引量:1

Research Progress of TRF and Its Role in Tumors
在线阅读 下载PDF
导出
摘要 转运RNA衍生片段属于非编码小RNA家族成员。TRF具有多种生物学功能,包括作为应激反应中的信号分子和基因表达的调节因子。此外,TRF还参与RNA加工、细胞增殖、翻译抑制、基因表型的遗传、细胞凋亡和免疫调节。TRF与癌症的发生、进展和化疗耐药有密切关系,在乳腺癌及其耐药细胞、前列腺癌、结直肠癌组织中明显高表达。肿瘤细胞中特异性表达TRF,研究其在乳腺癌耐药中的作用机制,可能使其成为一种新的生物学标志物来指导临床诊断和治疗。 Transfer RNA-derived fragments(TRF),belong to the family of non-coding microRNAs.TRF has a variety of biological functions,including acting as a signal molecule in stress response and a regulator of gene expression.In addition,TRF are involved in RNA processing,cell proliferation,translational inhibition,genetic phenotypic inheritance,apoptosis,and immune regulation.TRF is closely related to the occurrence,progression and chemotherapy resistance of cancer,and is highly expressed in breast cancer and its resistant cells,prostate cancer and colorectal cancer tissues.The discovery of TRF specifically expressed in tumor cells and its mechanism of action in breast cancer resistance may make it a new biomarker to guide the clinical diagnosis and treatment.
作者 单世婷 朱春富 SHAN Shiting;ZHU Chunfu(Graduate School of Nanjing Medical University,Nanjing 210029,China;Changzhou No.2 People′s Hospital Affiliated to Nanjing Medical University,Changzhou 213000,China)
出处 《医学综述》 2020年第8期1526-1530,共5页 Medical Recapitulate
关键词 转运RNA 转运RNA衍生的小RNA 转运RNA衍生片段 肿瘤 化疗耐药 Transfer RNA tRNA-derived small RNA Transfer RNA-derived fragments Tumor Chemotherapy resistance
作者简介 通信作者:朱春富,Email:zcfmlm@163.com。
  • 相关文献

参考文献2

二级参考文献38

  • 1Siegel R, Naishadham D, Jemal A. Cancer statistics lbr Hispanics/ Latinos, 21112. CA Cancer J Clin 2012;62:283-98.
  • 2Ramalingam SS, Owonikoko TK, Khuri FR. Lung cancer: New biological insights and recent therapeutic advances. CA Cancer J Clin 2011;61:91-112.
  • 3SEER Stat Fact Sheets: Lung and Bronchus Cancer. National Cancer Institute; 2014. http://www, scer.caneer.gov /statfacts/html/lungb.html. [Last accessed on 21114 Nov 30].
  • 4Somasundaram A, Socinski MA, Burns TF. Personalized treatment of EGFR mutant and ALK-positivc patients in NSCLC. Expert Opin Pllarmacotber 2014; 15:2693-7118.
  • 5Mostalh AA, Morris DG. Inlrnunothcrapy tbr lung cancer: Has it finally arrived'? Front Oncol 2014;4:288.
  • 6Krol J, Loedige 1, Filipowicz W. The widespread regulation ot'microRNA biogenesis, function and decay. Nat Re,,' Genet 2010; ! 1:597-610.
  • 7Zhong Z, Dong Z, Yang L, Gong Z. miR-21 induces cell cycle at S phase and modulates cell proliferation by down-regulating hMSH2 in hmg cancer. J Cancer Res Clin Oncol 2012;138:1781-8.
  • 8lorio MV, Croce CM. microRNAs in cancer: Small molecules with a huge impact. J Clin Oncol 21109;27:5848-56.
  • 9Kumar MS, Erkeland S J, Pester RE, Chen CY, Ebert MS, Sharp PA, et al. Suppression of non-small cell lung tumor development by the let-7 microRNA thrnily. Proc Natl Acad Sci U S A 2008;105:3903-8.
  • 10Yanaihara N, Caplen N, Bowman E, Seike M, Kumamoto K, Yi M, et aL Unique microRNA molecular profiles in lung cancer diagnosis and prognosis. Cancer Cell 2006;9:189-98.

共引文献18

同被引文献7

引证文献1

二级引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部